ViroGates A/S
VIRO.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.13 | -0.03 | 0.37 | 4.23 |
| FCF Yield | -16.92% | -55.16% | -8.43% | -3.64% |
| EV / EBITDA | -4.39 | -0.91 | -15.05 | -30.90 |
| Quality | ||||
| ROIC | -98.67% | -52.05% | -59.79% | -106.53% |
| Gross Margin | 52.36% | 83.08% | 83.28% | 75.60% |
| Cash Conversion Ratio | 0.83 | 1.01 | 1.48 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | -31.44% | -3.00% | 41.59% | 28.81% |
| Free Cash Flow Growth | 1.90% | 14.69% | 33.40% | -36.40% |
| Safety | ||||
| Net Debt / EBITDA | 0.48 | 0.86 | 0.93 | 0.80 |
| Interest Coverage | -25.54 | -22.08 | -96.83 | -96.85 |
| Efficiency | ||||
| Inventory Turnover | 0.83 | 0.23 | 0.67 | 1.10 |
| Cash Conversion Cycle | 516.94 | 1,221.42 | 517.50 | 351.49 |